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Purpose: Few reports of aortoiliac aneurysms infected by Campylobacter fetus are available. We report five cases and review
previous reports, with a view to describing the clinical pattern, treatment options, and outcome of this infection.
Methods: During a 10-year period, 21 patients were diagnosed with C fetus infection in the Department of Clinical
Microbiology, five of whom had an infected arterial aneurysm. We retrospectively reviewed their medical charts.
Diagnosis was made on the basis of clinical presentation, computed tomography scan, perioperative findings, and
identification of C fetus in at least one blood culture or culture from an aneurysm specimen. Late outcome of surviving
patients was assessed by telephone interview.
Results: We identified four aortic aneurysms and one hypogastric aneurysm. All patients were seen in an emergency
setting. Five had fever and abdominal pain, and three had contained rupture. Campylobacter fetus was found in blood
cultures of four patients and in the aneurysm specimen of one patient. Three patients were treated by open repair and two
by endovascular repair. One patient treated endovascularly died from septic shock due to C fetus at 2 weeks. One patient
treated by open surgery underwent reoperation for persistent infection. The remaining patients were cured, but one died
at 5 months of an unrelated cause. All surviving patients received long-term antibiotic therapy.
Conclusion: Campylobacter fetus infection of aortoiliac aneurysms is a serious condition with a high rate of rupture.
However, long-term success can be obtained with prompt surgical treatment and an appropriate antibiotic regimen. The
benefits of stent grafts remain debatable. ( J Vasc Surg 2008;48:815-20.)Infected abdominal aortic aneurysms (AAA) are rare
and remain one of the most challenging issues for vascular
surgeons. Traditionally, the most frequently reported or-
ganisms are Salmonella, Staphylococcus, and Streptococ-
cus.1,2 Recently, an increasing number of other organisms
have been found that have changed the spectrum of AAA
infections. During the two last decades, Campylobacter
fetus has emerged as a pathogen responsible for serious
systemic disease, with bacteremia and propensity to invade
the vascular endothelium. Few studies on AAA infected by
C fetus have been published since the first case was reported
by Dolev et al.3-17 We analyzed all cases of AAA infected by
C fetus diagnosed in our institution during the past 10 years
and reviewed previous English-language publications to
better define the epidemiologic, clinical, and bacteriologic
characteristics of the disease and treatment options.
PATIENTS AND METHODS
We reviewed data from the Henri Mondor Hospital
microbiology laboratory between 1997 and 2006 to iden-
tify C fetus infections and found 21 cases.
Blood cultures were grown in an automated BacT/
Alert system (bioMérieux, Marcy l’Etoile, France) at the
Department of Clinical Microbiology. Direct examination
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doi:10.1016/j.jvs.2008.05.076showed gram-negative spirally curved and actively motile
rods. The organisms were grown on Columbia blood agar
and chocolate agar incubated in microaerophilic condi-
tions. Organisms were identified by an oxidase-positive
reaction, with an ability to grow at 25° and 37°C but not at
42°C and by using the API Campy strip (bioMérieux). If
necessary, identification was further confirmed with a mo-
lecular method: DNA extraction using the QIAamp DNA
minikit (Qiagen, Hilden, Germany), polymerase chain reac-
tion amplification and sequence analysis of an internal frag-
ment of the 16S rDNA, as described by Bosshard et al.18
Susceptibility to antibiotics was tested using a disk diffu-
sion method on Mueller-Hinton blood agar according to the
guidelines of the Comité de l’Antibiogramme de la Société
Française de Microbiologie.19 Minimum inhibitory concen-
trations were determined by the E-test (AB Biodisk, Solna,
Sweden) according to the manufacturer’s recommendations.
We retrospectively analyzed the case report forms for the
21 patients and identified four AAAs and one hypogastric
aneurysm infected by C fetus. The diagnosis of aortic or
hypogastric infection by C fetus was based on clinical presen-
tation, computed tomography (CT) scan, perioperative find-
ings, and identification of C fetus in at least one blood culture
or culture from an aneurysm specimen. Late outcomes of
surviving patients were assessed by telephone interview. The
median follow-up was 12 months (range, 2 weeks-6 years).
RESULTS
All patients were men with a mean age of 76  4 years
(range, 69-79 years). Detailed data concerning clinical
pattern, treatment options, and outcome are presented in
Table I.
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nal or back pain and fever. The abdominal pain was sudden
in four patients, but none of them were hemodynamically
unstable. Other major clinical features were asthenia and
weight loss (n  2) and gastrointestinal symptoms with
diarrhea (n  1). All patients had multiple comorbidities,
including coronary artery disease (n  3), hypertension
(n  3), peripheral vascular disease (n  1), and chronic
obstructive pulmonary disease. Four patients had immuno-
deficiency caused by severe alcoholism (n  1) or malig-
nancy (n  3). Pre-existence of an arterial aneurysm was
known before admission only for the patient with the
hypogastric aneurysm. This patient had been treated by
embolization 18 months before. Physical examination re-
vealed an abdominal pulsating mass in four patients. Leu-
kocytosis was present in all patients.
CT scan confirmed diagnosis of contained ruptured
AAA in three patients. CT scan in the patient with the
hypogastric aneurysm showed a rapidly enlarging aneurysm
that grew from 30 to 70 mm in 8 months. Mean maximal
diameter was 82.6  19.1 mm (range, 60-110 mm). An-
eurysms in three patients had an irregular and saccular
shape, whereas fusiform aneurysms were observed in the
other two patients. One patient had a thickened aortic wall,
which was interpreted as an inflammatory aneurysm.
Bacteriologic findings. Campylobacter fetus was iso-
lated from the blood cultures of four patients. Among these
patients, cultures from surgical specimens were negative (n
 2) or were not tested (n  2). Blood cultures in one
patient were negative, but C fetus was recovered from
specimens of the excised aneurysm and intraluminal throm-
bus. All patients received antibiotics before surgery.
The primary source of infection remained unknown in
all cases. Campylobacter fetus grew in blood culture in a
median of 2 days. Because of the rarity of digestive symp-
Table I. Presentation, treatment, and outcome in patients w
Patient Age/sex Pre-existing illness Sym
1 69/M Chronic lymphocytic
leukemia, COPD,
CAD
Fever, abdo
fatigue, w
2 76/M Tuberculosis,
alcoholism
Fever, back
weight lo
3 76/M COPD, CAD Fever, abdo
4 79/M Lung cancer, COPD,
CAD, PVD, iliac
aneurysm
Fever, abdo
diarrhea
5 79/M Pancreatic cancer Fever, abdo
AAA, Abdominal aortic aneurysm; A/W, alive and well; CAD, coronary
tomography; ND, not done; PVD, peripheral vascular disease.toms, stool cultures were not tested. All C fetus isolateswere susceptible to amoxicillin, amoxicillin-clavulanate,
imipenem, gentamicin, and chloramphenicol. Two strains
had intermediate susceptibility to cefotaxime. One isolate
was resistant to ciprofloxacin, two isolates were resistant to
tetracycline, and one was resistant to erythromycin. As
expected, all isolates were resistant to nalidixic acid.
Treatment. Operations were done as emergency pro-
cedures for four patients, and elective surgery was done for
one. We performed open surgery in three cases and endo-
vascular repair in two. Open surgery consisted of local
débridement of the aneurysm wall and infected tissues with
in situ reconstruction. In situ reconstructions included
interposition of a polyester graft in two patients because the
infectious process had not been recognized preoperatively
and aortoaortic bypass grafting with an arterial cryopre-
served allograft in one patient. Endovascular procedures
were performed using a Zenith (Cook, Bloomington, Ind)
bifurcated stent graft (n  1) and a Zenith aortomonoiliac
stent graft associated with a prosthetic femorofemoral by-
pass (n  1). Although the diagnosis of infected aneurysm
had been established preoperatively in one of those pa-
tients, we decided to treat him endovascularly because of
multiple comorbidities. In the other patient who received
endovascular treatment, the infectious process had not
been recognized preoperatively.
Among the patients treated by open repair, no purulent
material was evident at surgery. The patient with the in-
flammatory aneurysm detected by CT scan had a fibrous
adhesion to the mesentery, retroperitoneal edema, and a
thickened aneurysm wall. No aortoenteric fistula was de-
tected.
Patients received various antibiotic regimens. Initial
treatment was mostly based on intravenous amoxicillin-
clavulanate (n  3) or imipenem (n  3), alone or com-
bined with gentamicin. Treatment was switched to oral
bdominal aortic aneurysm infected by Campylobacter fetus
Maximal transverse
diameter on CT
scan (mm) Findings on CT scan
pain,
loss
89 Contained ruptured AAA
fatigue, 84 Contained ruptured AAA
pain 110 Contained ruptured AAA,
periaortic bubbles
pain, 70 Rapidly enlarging
hypogastric aneurysm
pain 60 Inflammatory AAA
y disease; COPD, chronic obstructive pulmonary disease; CT, computedith a
ptoms
minal
eight
pain,
ss
minal
minal
minalamoxicillin (n 2) or amoxicillin-clavulanate (n 3) once
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decreased. At discharge, surviving patients were prescribed
long-term antibiotic therapy.
Outcome. Two patients died during the follow-up
period. One, who had a contained ruptured AAA at admis-
sion, died from septic shock due toC fetus 2 weeks after the
operation. This patient had received endovascular treat-
ment because the C fetus infection was not diagnosed
preoperatively. One patient who underwent interposition
with a polyester tube graft died 5 months after the opera-
tion from an unrelated cause. He did not present any sign of
recurrent infection on a follow-up CT scan 2 months
before. Among the three remaining patients, symptoms in
two cleared without clinical or radiologic evidence of recur-
rent infection, one at 18 months and the other at 6 years.
Treatment consisted of open surgery with interpositioning
of an allograft in one patient and a Zenith aortomonoiliac
stent graft in the other. One patient had persistent infec-
tion. This patient had been treated by interposition of a
polyester graft, and fever did not subside after surgical
treatment despite appropriate antibiotic therapy. A follow-
up CT scan revealed the presence of perigraft fluid (Fig).
He underwent reoperation consisting of complete pros-
thetic graft removal and reconstruction with aortofemoral
and femorofemoral bypasses using autogenous femoral su-
perficial veins 2 weeks after the first operation. He was free
of symptoms 6 months after reoperation.
DISCUSSION
In the past, Campylobacter species have been typically
considered as pathogens of a wide range of domestic ani-
mals. However, they are now increasingly implicated in
human disease. The Campylobacter genus contains three
main pathogenic species: C jejuni, C coli, and C fetus.
Campylobacter jejuni and to a lesser extent C coli are major
causes of enterically transmitted bacterial syndromes, rang-
Table I. Continued
Blood culture Specimen culture Time of diagnosis
Positive Negative Post-op Dacron
Negative Positive Post-op Dacron
Positive ND Post-op Zenith
Positive ND Pre-op Zenith
Positive Negative Pre-op Aortoa
artering from asymptomatic carriage to dysentery and inflam-matory ileocolitis. They affect all ages and healthy patients.
These organisms are recovered from the feces and, in rare
cases, can be simultaneously grown from the blood. In
contrast, C fetus is rarely isolated from stools and shows a
special tropism for the human vascular endothelium. It is
responsible for serious infections in elderly or immunosup-
pressed patients20 and has been associated with relapsing
bacteremia,21 endocarditis,22 pericarditis,23 thrombophle-
bitis,24 meningitidis,25 arthritis,26 osteomyelitis,27 cellu-
litis,28 pneumonia,29 and mycotic aneurysms.30 However,
involvement of C fetus in infected aortic aneurysms is rare,
and to the best of our knowledge, only 15 cases have been
previously published in English.3-17
Until a few years ago, C fetus infections were probably
underdiagnosed. Nowadays, they seem to be recognized
more frequently because of improved bacteriologic tech-
nologies, medical awareness, and a growing number of
immunodeficient patients.31 The epidemiology and patho-
genesis of C fetus infections are yet to be fully understood
due to the rarity of the disease. Different modes of trans-
mission have been suggested: direct contact with animals,
ingestion of contaminated food or water, and spread by
endogenous route.5,20 Among our patients, the primary
source of infection was unknown, and none of them re-
ported contact with animals. The vascular tropism of C
fetus has been linked to the presence of a surface receptor
with high affinity to the endothelium and production of a
local procoagulant that promotes thrombus formation.32
Campylobacter fetus is typically distinguished from C jejuni
and C coli on the basis of its ability to grow well at 25° and
37°C, but not at 42°C, and its susceptibility to cephalothin
but resistance to nalidixic acid.
Diagnosis of the disease is based on clinical presenta-
tion, CT scan, perioperative findings, and identification of
C fetus in blood cultures or from specimens of the aneu-
rysm. In our patient series, the most common symptoms
peration Outcome
cated graft Prosthetic infection by C fetus 2 weeks
post-op. Reintervention: prosthetic
graft excision, aortofem and femfem
bypasses with autogenous superficial
fem vein. A/W at 6 months
graft Death unrelated to infection 5 months
post-op
cated stent graft Septic shock and death 2 weeks post-op
monoiliac stent graft A/W at 6 years. No recurrent infection
bypass grafting with
opreserved allograft
A/W at 18 months. No recurrent
infectionO
bifur
tube
bifur
aorto
ortic
ial crywere fever and abdominal or back pain. Three patients
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tent with other studies: among 15 previously reported
patients, 8 (53%) had a ruptured aneurysm.3-5,7,10,12,14,15
Neither symptoms nor CT scan results are specific to
AAAs infected by C fetus. Indeed, CT scans may show a
saccular shape of the aneurysm, a thickened aortic wall, or
periaortic ectopic gas; all these abnormalitiesmaybe present in
patients with AAA infected by other organisms.33 However,
of particular interest in our series, we additionally identified an
inflammatory aneurysm in one patient. No previous study has
demonstrated that inflammatory aneurysms are more suscep-
tible to bacterial infection, but the ability for C fetus to infect
inflammatory aortic aneurysms has already been proposed by
Marty et al.7 This observation was based on the association of
acute neutrophil infiltration with the chronic inflammatory
infiltrate of inflammatory aneurysms. In one of our patients,
the aortic aneurysm enlarged very rapidly. This characteristic
has previously been reported, in some cases resulting in rup-
ture.8,10,11,13 None of our patients had periaortic collection.
This is consistent with previous studies in which fibrous reac-
tion in the retroperitoneum was far more common than
Fig. A, This computed tomography (CT) scan was obtained in a
patient with a ruptured abdominal aortic aneurysm infected by
Campylobacter fetus that was treated by open surgery with interposi-
tion of a polyester graft. B, A control CT scan taken 10 days after
surgery disclosed persistent infection with periprosthetic collection.periaortic collection.Blood cultures were the only definitive diagnostic tool
for four patients. One patient, who received antibiotics
before blood samples were taken, remained negative, and
diagnosis was made by isolation of the organism from
multiple specimens of the aneurysmal wall. Some authors
recommend that incubation of cultures should be ex-
tended to 2 weeks because of the rather slow growth of
the organism.28
Similarly to other cases of aortic sepsis, management of
AAA infected by C fetus is very challenging.34,35 The most
appropriate surgical treatment remains unclear. Conven-
tional management of AAA sepsis involves excision of all
infected tissues and ligation of the infrarenal aorta, followed
by extra-anatomic arterial reconstruction. Despite its theo-
retic advantage of a lower risk of graft infection, this treat-
ment strategy has been associated with a significant mortal-
ity rate and adverse outcomes such as low 5-year patency
and high amputation rates, risk of dramatic aortic stump
blow-out, and thrombosis ascending toward the renal ar-
teries. Furthermore, intraoperative contamination of the
graft is not rare, and secondary infections have been noted
in 5% to 30% of cases in recent studies.36-40 None of our
patients underwent this procedure. Our current practice is
now to limit the indications for extra-anatomic reconstruc-
tion to infected patients in poor general condition and with
a short life expectancy. Among the 15 previously published
cases of AAA infected by C fetus, four were treated with
axillobifemoral bypass.6,8,12,13 Three were alive with no
apparent sign of recurrent infection at 45, 36, and 18
months, respectively, and one died on postoperative day 7
(Table II).3-17
To minimize the adverse effects of extra-anatomic re-
construction in AAA sepsis, alternative approaches have
been described. Recent studies have demonstrated that
in situ reconstruction with cryopreserved allografts,41-45
lower extremity deep veins,46 and standard,35,47 silver-
coated,48 or antibiotic-bonded38 prosthetic grafts give
long-term good results. However, no randomized trials have
been published, and comparisons among series are difficult
due to the heterogeneity of patients and different follow-up
strategies. Two of our patients and seven previously reported
patients with AAA infected by C fetus underwent reconstruc-
tion with prosthetic grafts. Of these patients, one died a few
hours after the operation, one died 5 months after the opera-
tion, six survived without recurrent infection with a median
follow-up period of 18 months (range, 6-36 months), and
one had persistent infection (Tables I and II).Despite success-
ful treatment ofC fetus-infectedAAApatients by interposition
of a prosthetic graft, this approach has been associated with
frequent reoperation with other gram-negative organisms.
We therefore recommend the use of cryopreserved allograft or
autogenous veins rather than a prosthetic graft in C fetus-
infected AAAs, but further studies are necessary.
Several reports demonstrating successful endovascular
repair of infected AAA associated with other organisms
have been published,49-51 and this technique may provide a
less invasive alternative. Endovascular treatment of infected
AAA has not been widely practiced, however, and its long-
ral byp
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suggested that the indications for this procedure should be
limited to aortic infections with low-virulence organisms
and absence of gross purulence.52 A major disadvantage is
the lack of débridement of infected tissues, which may
result in the spread of the septic process in the retroperito-
neum. Two patients in our series received endovascular
treatment. One died of sepsis. We could not determine
whether the septic shock was related to persistent infection
of retroperitoneal tissues or infection of the stent graft.
Débridement and drainage of the retroperitoneal collection
after stent graft implantation should have been discussed.
The other patient survived without sign of recurrent infec-
tion 6 years after operation, and to our knowledge, this is
the only published case to date of C fetus–infected AAA
successfully treated by endovascular repair.
Appropriate antimicrobial therapy based on susceptibil-
ity testing should be started immediately after diagnosis;
however, the optimal treatment of C fetus sepsis remains
poorly defined. Two in vitro studies done in Quebec found
significant differences in -lactam susceptibility31,53: al-
though all strains appeared susceptible to amoxicillin and
imipenem, the 90%minimal inhibitory concentrations were
markedly lower for imipenem (0.06 for imipenem; 2
g/mL for amoxicillin). The bactericidal activity of cefo-
taxime has been previously found to be lower than that of
amoxicillin or imipenem, and treatment failure with third-
generation cephalosporins has been reported.28 Erythro-
mycin is not recommended for the treatment of C fetus
bloodstream infection, despite in vitro susceptibility to this
drug, because several cases of failure have been reported.28
In our series, the three patients who were initially treated with
imipenem were cured. Two patients receiving amoxicillin-
clavulanate died. Although we cannot make any definite
conclusions based on a small number of cases, our data
suggest that imipenem should be the preferred first-line
agent for the treatment of arterial aneurysms infected by C
fetus. Depending on susceptibility tests, a switch to amoxi-
Table II. Treatment and outcome in published cases of ab
First author Age (years) Ruptured AAA O
Dolev3 68 Yes Replaced w
File4 63 Yes ND
Taylor5 67 Yes ND
Anolik6 73 No Aneurysm e
Marty7 54 Yes Replaced w
Blabey8 68 No Aneurysm e
Righter9 56 No Replaced w
Perry10 70 Yes Replaced w
Rutherford11 59 No Replaced w
Jacobs12 64 Yes Aneurysm e
Kato13 61 No Aneurysm e
Allerberger14 84 Yes ND
Grollier15 56 Yes Replaced w
Mii16 45 No Replaced w
Tran17 78 No Replaced w
AAA, Abdominal aortic aneurysm; A/W, alive and well; AXBF, axillofemocillin with or without clavulanate can be made once thesituation is stabilized. In previous reports, the postoperative
term for antibiotic treatment varied from 7 days9 to long-
term therapy.6 The optimal duration of treatment remains
uncertain, although a minimum of 3 to 4 weeks of intrave-
nous antimicrobial therapy has been advocated.19
CONCLUSIONS
AAA infected by C fetus is a serious disease with a high
rate of rupture. Among 20 reported cases, the 30-day
mortality rate was 29%. Early diagnosis, prompt surgical
treatment, and appropriate antibiotic therapy are essential.
Experience with endovascular repair is limited, but this
procedure may offer a benefit, especially in critically ill
patients.
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